BY ANJA HAUGE
-
Several weight loss products were advertised at the Super Bowl
Novo Nordisk, Eli Lilly, and digital health platforms all used this year’s most expensive advertising space to attract customers to GLP-1 drugs.
-
Novo investors’ confidence under pressure: “There is no room for further disappointments”
Numerous financiers see 2026 as a year for Novo Nordisk to reset and attempt to transform the trend. Yet, lots of continue to be dissatisfied with the firm’s assumptions for …
-
US chamber supports Novo Nordisk in legal conflict over drug price negotiations
Powerful lobby group gets involved in case that could change future drug price negotiations.
-
This is how Lundbeck’s price negotiations in the US will proceed
The brand-new costs are set up to find right into result from 2028.
-
ALK gets EU recommendation for children’s adrenaline nasal spray
The nasal spray has actually currently been accepted for kids and grownups evaluating greater than 30 kg.
-
Chinese biotech sector pressures Western rivals with rapid drug development
Significant licensing contracts, much shorter scientific tests, and brand-new kinds of treatment are changing the equilibrium of power in international medication growth.
-
Valneva’s chikungunya vaccine under investigation in Europe after serious side effect
Previously this month, the vaccination from Bavarian Nordic’s rival was taken out in the United States for the exact same factor.
-
Novo Nordisk chairman warns of repeat insulin price war in obesity business
Competitors for slendering medications triggers Lars Rebien Sørensen to attract parallels with the cost battles that formerly struck Novo Nordisk hard.
-
Trade deal with India could eliminate 11% medicine tariff
A huge section of the customizeds tasks on clinical devices is additionally readied to be gotten rid of.
-
Diabetes drug from Eli Lilly selected for new round of Medicare price negotiations
The United States is boosting rate stress on pricey medicines, while the pharmaceutical market alerts of the effects.
